Product logins

Find logins to all Clarivate products below.


Blog: Biopharma

Here you will find relevant articles and insight into all Clarivate related products and news.

Tracking the mid-year momentum of the 2026 Drugs to Watch Tracking the mid-year momentum of the 2026 Drugs to Watch
Blog July 8, 2026
Tracking the mid-year momentum of the 2026 Drugs to Watch
Biopharma Biotech Clinical trials
BioWorld: celebrating recognition, reaffirming our mission BioWorld: celebrating recognition, reaffirming our mission
Blog July 1, 2026
BioWorld: celebrating recognition, reaffirming our mission
Biopharma Dealmaking M&A
Navigating global risk in the pharmaceutical supply chain Navigating global risk in the pharmaceutical supply chain
Blog June 26, 2026
Navigating global risk in the pharmaceutical supply chain
Biopharma CMC Commercialization
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
Blog June 24, 2026
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
ADC Biopharma Biotech
From complexity to clarity: Why patient-centered communication matters From complexity to clarity: Why patient-centered communication matters
Blog June 24, 2026
From complexity to clarity: Why patient-centered communication matters
Biopharma Biotech Commercialization
The rise of the AI analyst: How agentic AI will reshape life sciences consulting The rise of the AI analyst: How agentic AI will reshape life sciences consulting
Blog June 24, 2026
The rise of the AI analyst: How agentic AI will reshape life sciences consulting
Europe looks to shore up global competitiveness with the E.U. Biotech Act Europe looks to shore up global competitiveness with the E.U. Biotech Act
Blog June 22, 2026
Europe looks to shore up global competitiveness with the E.U. Biotech Act
Biopharma Biotech Business Development
The competitive intelligence workflow problem in pharma: a diagnostic framework The competitive intelligence workflow problem in pharma: a diagnostic framework
Blog June 12, 2026
The competitive intelligence workflow problem in pharma: a diagnostic framework
Biopharma Business Development Dealmaking

Biopharma

Balancing the promise of targeted protein degradation with real-world safety insights Balancing the promise of targeted protein degradation with real-world safety insights
Blog June 3, 2026
Balancing the promise of targeted protein degradation with real-world safety insights
Blog June 2, 2026
One drug, seven names: the hidden complexity of pharmaceutical competitive intelligence data
The competitive signals hiding in plain sight for biopharma The competitive signals hiding in plain sight for biopharma
Blog May 8, 2026
The competitive signals hiding in plain sight for biopharma
Five lessons learned deploying agentic AI in the life sciences Five lessons learned deploying agentic AI in the life sciences
Blog April 30, 2026
Five lessons learned deploying agentic AI in the life sciences
Target selection and safety assessment: Navigating early decisions that shape drug development Target selection and safety assessment: Navigating early decisions that shape drug development
Blog March 27, 2026
Target selection and safety assessment: Navigating early decisions that shape drug development
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
Blog March 26, 2026
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar